The Roles of Lpar1 in Central Nervous System Disorders and Diseases

被引:16
作者
Xiao, Dongqiong [1 ,2 ]
Su, Xiaojuan [1 ]
Gao, Hu [2 ]
Li, Xihong [2 ]
Qu, Yi [1 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Dept Pediat,Minist Educ, Chengdu, Peoples R China
[2] Sichuan Univ, West China Second Univ Hosp, Dept Emergency, Minist Educ,Key Lab Birth Defects & Related Dis W, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lpar1; Edg2; astroglia; microglia; oligodendrocyte; astrocyte; LYSOPHOSPHATIDIC ACID RECEPTOR; NEURAL STEM-CELLS; LPA(1) RECEPTOR; BLOOD BIOMARKERS; GENE-EXPRESSION; DEFICIENT MICE; ACTIVATION; PROTEIN; BRAIN; OLIGODENDROCYTES;
D O I
10.3389/fnins.2021.710473
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lysophosphatidic acid receptor 1 (Lpar1), which is found in almost all human tissues but is most abundant in the brain, can couple to G protein-coupled receptors (GPCRs) and participate in regulating cell proliferation, migration, survival, and apoptosis. Endothelial differentiation gene-2 receptor (Edg2), the protein encoded by the Lpar1 gene, is present on various cell types in the central nervous system (CNS), such as neural stem cells (NSCs), oligodendrocytes, neurons, astrocytes, and microglia. Lpar1 deletion causes neurodevelopmental disorders and CNS diseases, such as brain cancer, neuropsychiatric disorders, demyelination diseases, and neuropathic pain. Here, we summarize the possible roles and mechanisms of Lpar1/Edg2 in CNS disorders and diseases and propose that Lpar1/Edg2 might be a potential therapeutic target for CNS disorders and diseases.
引用
收藏
页数:13
相关论文
共 81 条
  • [1] Abe Hiromi, 2019, Neuropsychopharmacology Reports, V39, P156, DOI 10.1002/npr2.12055
  • [2] Allard J, 1999, GLIA, V26, P176, DOI 10.1002/(SICI)1098-1136(199904)26:2<176::AID-GLIA8>3.0.CO
  • [3] 2-K
  • [4] A rat G protein-coupled receptor selectively expressed in myelin-forming cells
    Allard, J
    Barrón, S
    Diaz, J
    Lubetzki, C
    Zalc, B
    Schwartz, JC
    Sokoloff, P
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (03) : 1045 - 1053
  • [5] Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid
    An, SZ
    Dickens, MA
    Bleu, T
    Hallmark, OG
    Goetzl, EJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) : 619 - 622
  • [6] Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder
    Aston, C
    Jiang, L
    Sokolov, BP
    [J]. MOLECULAR PSYCHIATRY, 2005, 10 (03) : 309 - 322
  • [7] Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases
    Bartels, Tim
    De Schepper, Sebastiaan
    Hong, Soyon
    [J]. SCIENCE, 2020, 370 (6512) : 66 - +
  • [8] Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes
    Bauer, J
    Bradl, M
    Klein, M
    Leisser, M
    Deckwerth, TL
    Wekerle, H
    Lassmann, H
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (01) : 12 - 22
  • [9] Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture
    Bernhart, Eva
    Kollroser, Manfred
    Rechberger, Gerald
    Reicher, Helga
    Heinemann, Akos
    Schratl, Petra
    Hallstroem, Seth
    Wintersperger, Andrea
    Nusshold, Christoph
    DeVaney, Trevor
    Zorn-Pauly, Klaus
    Malli, Roland
    Graier, Wolfgang
    Malle, Ernst
    Sattler, Wolfgang
    [J]. PROTEOMICS, 2010, 10 (01) : 141 - 158
  • [10] Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia
    Bowden, NA
    Weidenhofer, J
    Scott, RJ
    Schall, U
    Todd, J
    Michie, PT
    Tooney, PA
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 82 (2-3) : 175 - 183